Literature DB >> 17101178

Age-related functional and histopathological changes of the ear in the MPS I mouse.

Patricia A Schachern1, Sebahattin Cureoglu, Vladimir Tsuprun, Michael M Paparella, Chester B Whitley.   

Abstract

OBJECTIVE: Mucopolysaccharidosis type I (MPS I) is an autosomal recessive disorder caused by a mutation in the gene encoding the enzyme alpha-L-iduronidase. This enzyme is responsible for degradation of dermatan and heparan sulfates. Enzyme deficiency results in their accumulation in lysosomes of virtually all organs, resulting in severe somatic and neurological changes. Clinical findings of otitis media with mixed hearing loss are common. Cellular and molecular mechanisms of ear pathology and hearing loss are not understood. The purpose of this study is to describe the age-related audiologic and histopathologic changes of the ear in the mouse model of MPS I.
METHODS: Auditory brainstem responses (ABR) were obtained to clicks and tone bursts at 1-32kHz, and pathological changes to middle and inner ears were studied with light and electron microscopy in 53 mice that included: (1) wild type (+/+)-five at 2 months, five at 4-6 months, and five at 13-19 months; (2) heterozygotes (+/-)-four at 2 months, five at 4-6 months, and eight at 13-19 months; and (3) homozygotes (-/-)-five at 2 months, six at 4-6 months, and five at 13-19 months. Histopathology was also done on five newborn -/- mice.
RESULTS: In newborns, no lysosomal storage was observed and the ear appeared age appropriately normal. In all other -/- mice, cells with lysosomal storage vacuoles were observed in spiral ligament, spiral prominence, spiral limbus, basilar membrane, epithelial and mesothelial cells of Reissner's membrane, endothelial cells of vessels, and some ganglion cells; their number increased with aging. Hair cell loss was not observed at 2 or 6 months, but there was total loss of the organ of Corti in year-old mice. Hearing of -/- mice was significantly decreased at all ages compared to +/+ and +/-. Hearing loss progressed from mild to moderate loss at 2 months to profound at 6 months and total deafness by 1 year of age.
CONCLUSIONS: Progressive age-related changes suggest early therapeutic intervention to prevent sensory cell damage and hearing loss.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101178      PMCID: PMC1940035          DOI: 10.1016/j.ijporl.2006.09.016

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  17 in total

1.  Hurler disease.

Authors:  Celil Gocer; Fred H Linthicum
Journal:  Otol Neurotol       Date:  2004-01       Impact factor: 2.311

Review 2.  Otorhinolaryngological manifestations of the mucopolysaccharidoses.

Authors:  M A Simmons; I A Bruce; S Penney; E Wraith; M P Rothera
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2005-05       Impact factor: 1.675

3.  Differentiation of inner ear fibrocytes according to their ion transport related activity.

Authors:  S S Spicer; B A Schulte
Journal:  Hear Res       Date:  1991-11       Impact factor: 3.208

4.  ABR and temporal bone pathology in Hurler's disease.

Authors:  Y Komura; K Kaga; Y Ogawa; Y Yamaguchi; T Tsuzuku; J I Suzuki
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1998-03-01       Impact factor: 1.675

5.  Immunohistochemical localization of the Na-K-Cl co-transporter (NKCC1) in the gerbil inner ear.

Authors:  J J Crouch; N Sakaguchi; C Lytle; B A Schulte
Journal:  J Histochem Cytochem       Date:  1997-06       Impact factor: 2.479

6.  The Pendred syndrome gene encodes a chloride-iodide transport protein.

Authors:  D A Scott; R Wang; T M Kreman; V C Sheffield; L P Karniski
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

7.  Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice.

Authors:  Yuli Liu; Lingfei Xu; Anne K Hennig; Attila Kovacs; Annabel Fu; Sarah Chung; David Lee; Bin Wang; Ramin S Herati; Judith Mosinger Ogilvie; Shi-Rong Cai; Katherine Parker Ponder
Journal:  Mol Ther       Date:  2005-01       Impact factor: 11.454

8.  Mucopolysaccharidosis I-H (Hurler's syndrome) and human temporal bone histopathology.

Authors:  P A Schachern; D A Shea; M M Paparella
Journal:  Ann Otol Rhinol Laryngol       Date:  1984 Jan-Feb       Impact factor: 1.547

9.  Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene.

Authors:  Seth D Hartung; Joel L Frandsen; Dao Pan; Brenda L Koniar; Patrick Graupman; Roland Gunther; Walter C Low; Chester B Whitley; R Scott McIvor
Journal:  Mol Ther       Date:  2004-06       Impact factor: 11.454

10.  Pathology of the ear in murine mucopolysaccharidosis type VII. Morphologic correlates of hearing loss.

Authors:  C L Berry; C Vogler; N J Galvin; E H Birkenmeier; W S Sly
Journal:  Lab Invest       Date:  1994-09       Impact factor: 5.662

View more
  16 in total

Review 1.  Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.

Authors:  Elena L Aronovich; Perry B Hackett
Journal:  Mol Genet Metab       Date:  2014-10-07       Impact factor: 4.797

Review 2.  Mouse models for human otitis media.

Authors:  Dennis R Trune; Qing Yin Zheng
Journal:  Brain Res       Date:  2009-03-06       Impact factor: 3.252

Review 3.  What have we learned from murine models of otitis media?

Authors:  Hayley E Tyrer; Michael Crompton; Mahmood F Bhutta
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

4.  Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome.

Authors:  Dao Pan; Anthony Sciascia; Charles V Vorhees; Michael T Williams
Journal:  Brain Res       Date:  2007-10-23       Impact factor: 3.252

5.  Retroviral-vector-mediated gene therapy to mucopolysaccharidosis I mice improves sensorimotor impairments and other behavioral deficits.

Authors:  Guilherme Baldo; David F Wozniak; Kevin K Ohlemiller; Yanming Zhang; Roberto Giugliani; Katherine P Ponder
Journal:  J Inherit Metab Dis       Date:  2012-09-15       Impact factor: 4.982

6.  Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice.

Authors:  Xudong Wu; Katherine A Steigelman; Erik Bonten; Huimin Hu; Wenxuan He; Tianying Ren; Jian Zuo; Alessandra d'Azzo
Journal:  Biochim Biophys Acta       Date:  2009-10-24

7.  Codeficiency of Lysosomal Mucolipins 3 and 1 in Cochlear Hair Cells Diminishes Outer Hair Cell Longevity and Accelerates Age-Related Hearing Loss.

Authors:  Teerawat Wiwatpanit; Natalie N Remis; Aisha Ahmad; Yingjie Zhou; John C Clancy; Mary Ann Cheatham; Jaime García-Añoveros
Journal:  J Neurosci       Date:  2018-02-16       Impact factor: 6.167

Review 8.  Unraveling the genetics of otitis media: from mouse to human and back again.

Authors:  Marie S Rye; Mahmood F Bhutta; Michael T Cheeseman; David Burgner; Jenefer M Blackwell; Steve D M Brown; Sarra E Jamieson
Journal:  Mamm Genome       Date:  2010-11-25       Impact factor: 2.957

9.  Hearing loss in Pompe disease revisited: results from a study of 24 children.

Authors:  Carine I van Capelle; Andre Goedegebure; Nienke C Homans; Hans L J Hoeve; Arnold J Reuser; Ans T van der Ploeg
Journal:  J Inherit Metab Dis       Date:  2010-07-02       Impact factor: 4.982

Review 10.  Calcium signaling via two-pore channels: local or global, that is the question.

Authors:  Michael X Zhu; Jianjie Ma; John Parrington; Peter J Calcraft; Antony Galione; A Mark Evans
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.